Givaudan grows
This article was originally published in The Rose Sheet
Executive Summary
Swiss luxury firm will acquire Quest International, UK-based Imperial Chemical Industries' fragrance and flavor business, for $2.3 bil., it announces Nov. 22. The acquisition will expand Givaudan in all segments of the fragrance and flavor industry, a plan which is "fully in line with Givaudan's strategy to focus on developing markets and to capture opportunities in key segments and at key clients," company says. The decision will help grow the brand in Asia Pacific, Latin America, Eastern Europe, Africa and the Middle East, according to Givaudan. Subject to regulatory approval, the deal is expected to close in Q1 2007...
You may also be interested in...
Givaudan Predicts Quest Buy Will Prompt Rivals To Move Up In Weight Class
Givaudan expects its March 2 acquisition of Quest International - which the fragrance and flavor developer claims will make it 60 percent larger than its closest competitor - to compel similar movement throughout the industry
Givaudan sales and earnings
Swiss fragrance firm booked $2.34 bil. in sales for FY 2006, it announces Feb. 20. Both fragrance and flavor divisions of the company achieved above market sales growth despite continued ingredients streamlining, which impacted annual sales by $26.6 mil. The fragrance division recorded sales of $984.8 mil., a rise of 8.2% from FY 2005, driven by double-digit growth in fine fragrances and strong performances from consumer products and specialty ingredients. Givaudan attributes expansion of its market position in FY 2006 to new sales and growth strategies; the firm acquired Quest International in November for $2.3 bil. (1"The Rose Sheet" Nov. 27, 2006, In Brief)...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.